Dry Container Fleet
Dry Container Fleet market is segmented by players, region (country), by Type and by Application. ... Read More
Global Drug-Eluting Stent Market Research Report 2024
1 Drug-Eluting Stent Market Overview
1.1 Product Overview and Scope of Drug-Eluting Stent
1.2 Drug-Eluting Stent Segment by Type
1.2.1 Global Drug-Eluting Stent Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Rapamycin Eluting Stent
1.2.3 Paclitaxel Eluting Stent
1.2.4 Everolimus Eluting Stent
1.2.5 Others
1.3 Drug-Eluting Stent Segment by Application
1.3.1 Global Drug-Eluting Stent Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Drug-Eluting Stent Market Size Estimates and Forecasts
1.4.1 Global Drug-Eluting Stent Revenue 2017-2028
1.4.2 Global Drug-Eluting Stent Sales 2017-2028
1.4.3 Drug-Eluting Stent Market Size by Region: 2017 Versus 2021 Versus 2028
2 Drug-Eluting Stent Market Competition by Manufacturers
2.1 Global Drug-Eluting Stent Sales Market Share by Manufacturers (2017-2022)
2.2 Global Drug-Eluting Stent Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Drug-Eluting Stent Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Drug-Eluting Stent Manufacturing Sites, Area Served, Product Type
2.5 Drug-Eluting Stent Market Competitive Situation and Trends
2.5.1 Drug-Eluting Stent Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Drug-Eluting Stent Players Market Share by Revenue
2.5.3 Global Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug-Eluting Stent Retrospective Market Scenario by Region
3.1 Global Drug-Eluting Stent Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Drug-Eluting Stent Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Drug-Eluting Stent Market Facts & Figures by Country
3.3.1 North America Drug-Eluting Stent Sales by Country
3.3.2 North America Drug-Eluting Stent Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Drug-Eluting Stent Market Facts & Figures by Country
3.4.1 Europe Drug-Eluting Stent Sales by Country
3.4.2 Europe Drug-Eluting Stent Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Drug-Eluting Stent Market Facts & Figures by Region
3.5.1 Asia Pacific Drug-Eluting Stent Sales by Region
3.5.2 Asia Pacific Drug-Eluting Stent Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Drug-Eluting Stent Market Facts & Figures by Country
3.6.1 Latin America Drug-Eluting Stent Sales by Country
3.6.2 Latin America Drug-Eluting Stent Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Drug-Eluting Stent Market Facts & Figures by Country
3.7.1 Middle East and Africa Drug-Eluting Stent Sales by Country
3.7.2 Middle East and Africa Drug-Eluting Stent Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Drug-Eluting Stent Historic Market Analysis by Type
4.1 Global Drug-Eluting Stent Sales Market Share by Type (2017-2022)
4.2 Global Drug-Eluting Stent Revenue Market Share by Type (2017-2022)
4.3 Global Drug-Eluting Stent Price by Type (2017-2022)
5 Global Drug-Eluting Stent Historic Market Analysis by Application
5.1 Global Drug-Eluting Stent Sales Market Share by Application (2017-2022)
5.2 Global Drug-Eluting Stent Revenue Market Share by Application (2017-2022)
5.3 Global Drug-Eluting Stent Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Corporation Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Boston Scientific Drug-Eluting Stent Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Medtronic Drug-Eluting Stent Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Abbott Drug-Eluting Stent Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Lepu Medical
6.4.1 Lepu Medical Corporation Information
6.4.2 Lepu Medical Description and Business Overview
6.4.3 Lepu Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Lepu Medical Drug-Eluting Stent Product Portfolio
6.4.5 Lepu Medical Recent Developments/Updates
6.5 B. Braun Melsungen
6.5.1 B. Braun Melsungen Corporation Information
6.5.2 B. Braun Melsungen Description and Business Overview
6.5.3 B. Braun Melsungen Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
6.5.4 B. Braun Melsungen Drug-Eluting Stent Product Portfolio
6.5.5 B. Braun Melsungen Recent Developments/Updates
6.6 MicroPort Scientific
6.6.1 MicroPort Scientific Corporation Information
6.6.2 MicroPort Scientific Description and Business Overview
6.6.3 MicroPort Scientific Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
6.6.4 MicroPort Scientific Drug-Eluting Stent Product Portfolio
6.6.5 MicroPort Scientific Recent Developments/Updates
6.7 Cook Medical
6.6.1 Cook Medical Corporation Information
6.6.2 Cook Medical Description and Business Overview
6.6.3 Cook Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Cook Medical Drug-Eluting Stent Product Portfolio
6.7.5 Cook Medical Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Corporation Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Terumo Drug-Eluting Stent Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 Biosensors International
6.9.1 Biosensors International Corporation Information
6.9.2 Biosensors International Description and Business Overview
6.9.3 Biosensors International Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Biosensors International Drug-Eluting Stent Product Portfolio
6.9.5 Biosensors International Recent Developments/Updates
6.10 Balton
6.10.1 Balton Corporation Information
6.10.2 Balton Description and Business Overview
6.10.3 Balton Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Balton Drug-Eluting Stent Product Portfolio
6.10.5 Balton Recent Developments/Updates
6.11 AlviMedica Medical Technologies
6.11.1 AlviMedica Medical Technologies Corporation Information
6.11.2 AlviMedica Medical Technologies Drug-Eluting Stent Description and Business Overview
6.11.3 AlviMedica Medical Technologies Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
6.11.4 AlviMedica Medical Technologies Drug-Eluting Stent Product Portfolio
6.11.5 AlviMedica Medical Technologies Recent Developments/Updates
6.12 Biotronik
6.12.1 Biotronik Corporation Information
6.12.2 Biotronik Drug-Eluting Stent Description and Business Overview
6.12.3 Biotronik Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Biotronik Drug-Eluting Stent Product Portfolio
6.12.5 Biotronik Recent Developments/Updates
6.13 Shandong JW Medical
6.13.1 Shandong JW Medical Corporation Information
6.13.2 Shandong JW Medical Drug-Eluting Stent Description and Business Overview
6.13.3 Shandong JW Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Shandong JW Medical Drug-Eluting Stent Product Portfolio
6.13.5 Shandong JW Medical Recent Developments/Updates
6.14 Sino Medical
6.14.1 Sino Medical Corporation Information
6.14.2 Sino Medical Drug-Eluting Stent Description and Business Overview
6.14.3 Sino Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Sino Medical Drug-Eluting Stent Product Portfolio
6.14.5 Sino Medical Recent Developments/Updates
6.15 Beijing AMSINO
6.15.1 Beijing AMSINO Corporation Information
6.15.2 Beijing AMSINO Drug-Eluting Stent Description and Business Overview
6.15.3 Beijing AMSINO Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Beijing AMSINO Drug-Eluting Stent Product Portfolio
6.15.5 Beijing AMSINO Recent Developments/Updates
7 Drug-Eluting Stent Manufacturing Cost Analysis
7.1 Drug-Eluting Stent Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Drug-Eluting Stent
7.4 Drug-Eluting Stent Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Drug-Eluting Stent Distributors List
8.3 Drug-Eluting Stent Customers
9 Drug-Eluting Stent Market Dynamics
9.1 Drug-Eluting Stent Industry Trends
9.2 Drug-Eluting Stent Market Drivers
9.3 Drug-Eluting Stent Market Challenges
9.4 Drug-Eluting Stent Market Restraints
10 Global Market Forecast
10.1 Drug-Eluting Stent Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Drug-Eluting Stent by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Drug-Eluting Stent by Type (2023-2028)
10.2 Drug-Eluting Stent Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Drug-Eluting Stent by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Drug-Eluting Stent by Application (2023-2028)
10.3 Drug-Eluting Stent Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Drug-Eluting Stent by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Drug-Eluting Stent by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Drug-Eluting Stent Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Drug-Eluting Stent Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Drug-Eluting Stent Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Drug-Eluting Stent Market Competitive Situation by Manufacturers in 2021
Table 5. Global Drug-Eluting Stent Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Drug-Eluting Stent Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Drug-Eluting Stent Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Drug-Eluting Stent Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Drug-Eluting Stent Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Drug-Eluting Stent Manufacturing Sites and Area Served
Table 11. Manufacturers Drug-Eluting Stent Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Drug-Eluting Stent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug-Eluting Stent as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Drug-Eluting Stent Sales by Region (2017-2022) & (K Units)
Table 16. Global Drug-Eluting Stent Sales Market Share by Region (2017-2022)
Table 17. Global Drug-Eluting Stent Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Drug-Eluting Stent Revenue Market Share by Region (2017-2022)
Table 19. North America Drug-Eluting Stent Sales by Country (2017-2022) & (K Units)
Table 20. North America Drug-Eluting Stent Sales Market Share by Country (2017-2022)
Table 21. North America Drug-Eluting Stent Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Drug-Eluting Stent Revenue Market Share by Country (2017-2022)
Table 23. Europe Drug-Eluting Stent Sales by Country (2017-2022) & (K Units)
Table 24. Europe Drug-Eluting Stent Sales Market Share by Country (2017-2022)
Table 25. Europe Drug-Eluting Stent Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Drug-Eluting Stent Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Drug-Eluting Stent Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Drug-Eluting Stent Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Drug-Eluting Stent Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Drug-Eluting Stent Revenue Market Share by Region (2017-2022)
Table 31. Latin America Drug-Eluting Stent Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Drug-Eluting Stent Sales Market Share by Country (2017-2022)
Table 33. Latin America Drug-Eluting Stent Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Drug-Eluting Stent Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Drug-Eluting Stent Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Drug-Eluting Stent Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Drug-Eluting Stent Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Drug-Eluting Stent Revenue Market Share by Country (2017-2022)
Table 39. Global Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)
Table 40. Global Drug-Eluting Stent Sales Market Share by Type (2017-2022)
Table 41. Global Drug-Eluting Stent Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Drug-Eluting Stent Revenue Share by Type (2017-2022)
Table 43. Global Drug-Eluting Stent Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Drug-Eluting Stent Sales (K Units) by Application (2017-2022)
Table 45. Global Drug-Eluting Stent Sales Market Share by Application (2017-2022)
Table 46. Global Drug-Eluting Stent Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Drug-Eluting Stent Revenue Share by Application (2017-2022)
Table 48. Global Drug-Eluting Stent Price by Application (2017-2022) & (USD/Unit)
Table 49. Boston Scientific Corporation Information
Table 50. Boston Scientific Description and Business Overview
Table 51. Boston Scientific Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Boston Scientific Drug-Eluting Stent Product
Table 53. Boston Scientific Recent Developments/Updates
Table 54. Medtronic Corporation Information
Table 55. Medtronic Description and Business Overview
Table 56. Medtronic Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Medtronic Drug-Eluting Stent Product
Table 58. Medtronic Recent Developments/Updates
Table 59. Abbott Corporation Information
Table 60. Abbott Description and Business Overview
Table 61. Abbott Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Abbott Drug-Eluting Stent Product
Table 63. Abbott Recent Developments/Updates
Table 64. Lepu Medical Corporation Information
Table 65. Lepu Medical Description and Business Overview
Table 66. Lepu Medical Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Lepu Medical Drug-Eluting Stent Product
Table 68. Lepu Medical Recent Developments/Updates
Table 69. B. Braun Melsungen Corporation Information
Table 70. B. Braun Melsungen Description and Business Overview
Table 71. B. Braun Melsungen Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. B. Braun Melsungen Drug-Eluting Stent Product
Table 73. B. Braun Melsungen Recent Developments/Updates
Table 74. MicroPort Scientific Corporation Information
Table 75. MicroPort Scientific Description and Business Overview
Table 76. MicroPort Scientific Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. MicroPort Scientific Drug-Eluting Stent Product
Table 78. MicroPort Scientific Recent Developments/Updates
Table 79. Cook Medical Corporation Information
Table 80. Cook Medical Description and Business Overview
Table 81. Cook Medical Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Cook Medical Drug-Eluting Stent Product
Table 83. Cook Medical Recent Developments/Updates
Table 84. Terumo Corporation Information
Table 85. Terumo Description and Business Overview
Table 86. Terumo Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Terumo Drug-Eluting Stent Product
Table 88. Terumo Recent Developments/Updates
Table 89. Biosensors International Corporation Information
Table 90. Biosensors International Description and Business Overview
Table 91. Biosensors International Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Biosensors International Drug-Eluting Stent Product
Table 93. Biosensors International Recent Developments/Updates
Table 94. Balton Corporation Information
Table 95. Balton Description and Business Overview
Table 96. Balton Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Balton Drug-Eluting Stent Product
Table 98. Balton Recent Developments/Updates
Table 99. AlviMedica Medical Technologies Corporation Information
Table 100. AlviMedica Medical Technologies Description and Business Overview
Table 101. AlviMedica Medical Technologies Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. AlviMedica Medical Technologies Drug-Eluting Stent Product
Table 103. AlviMedica Medical Technologies Recent Developments/Updates
Table 104. Biotronik Corporation Information
Table 105. Biotronik Description and Business Overview
Table 106. Biotronik Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Biotronik Drug-Eluting Stent Product
Table 108. Biotronik Recent Developments/Updates
Table 109. Shandong JW Medical Corporation Information
Table 110. Shandong JW Medical Description and Business Overview
Table 111. Shandong JW Medical Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Shandong JW Medical Drug-Eluting Stent Product
Table 113. Shandong JW Medical Recent Developments/Updates
Table 114. Sino Medical Corporation Information
Table 115. Sino Medical Description and Business Overview
Table 116. Sino Medical Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Sino Medical Drug-Eluting Stent Product
Table 118. Sino Medical Recent Developments/Updates
Table 119. Beijing AMSINO Corporation Information
Table 120. Beijing AMSINO Description and Business Overview
Table 121. Beijing AMSINO Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Beijing AMSINO Drug-Eluting Stent Product
Table 123. Beijing AMSINO Recent Developments/Updates
Table 124. Production Base and Market Concentration Rate of Raw Material
Table 125. Key Suppliers of Raw Materials
Table 126. Drug-Eluting Stent Distributors List
Table 127. Drug-Eluting Stent Customers List
Table 128. Drug-Eluting Stent Market Trends
Table 129. Drug-Eluting Stent Market Drivers
Table 130. Drug-Eluting Stent Market Challenges
Table 131. Drug-Eluting Stent Market Restraints
Table 132. Global Drug-Eluting Stent Sales Forecast by Type (2023-2028) & (K Units)
Table 133. Global Drug-Eluting Stent Sales Market Share Forecast by Type (2023-2028)
Table 134. Global Drug-Eluting Stent Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 135. Global Drug-Eluting Stent Revenue Market Share Forecast by Type (2023-2028)
Table 136. Global Drug-Eluting Stent Sales Forecast by Application (2023-2028) & (K Units)
Table 137. Global Drug-Eluting Stent Sales Market Share Forecast by Application (2023-2028)
Table 138. Global Drug-Eluting Stent Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 139. Global Drug-Eluting Stent Revenue Market Share Forecast by Application (2023-2028)
Table 140. Global Drug-Eluting Stent Sales Forecast by Region (2023-2028) & (K Units)
Table 141. Global Drug-Eluting Stent Sales Market Share Forecast by Region (2023-2028)
Table 142. Global Drug-Eluting Stent Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 143. Global Drug-Eluting Stent Revenue Market Share Forecast by Region (2023-2028)
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drug-Eluting Stent
Figure 2. Global Drug-Eluting Stent Market Share by Type in 2021 & 2028
Figure 3. Rapamycin Eluting Stent Product Picture
Figure 4. Paclitaxel Eluting Stent Product Picture
Figure 5. Everolimus Eluting Stent Product Picture
Figure 6. Others Product Picture
Figure 7. Global Drug-Eluting Stent Market Share by Application in 2021 & 2028
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Ambulatory Surgical Centers
Figure 11. Others
Figure 12. Global Drug-Eluting Stent Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Drug-Eluting Stent Market Size (2017-2028) & (US$ Million)
Figure 14. Global Drug-Eluting Stent Sales (2017-2028) & (K Units)
Figure 15. Drug-Eluting Stent Sales Share by Manufacturers in 2021
Figure 16. Global Drug-Eluting Stent Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Drug-Eluting Stent Players: Market Share by Revenue in 2021
Figure 18. Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Drug-Eluting Stent Sales Market Share by Region (2017-2022)
Figure 20. Global Drug-Eluting Stent Sales Market Share by Region in 2021
Figure 21. Global Drug-Eluting Stent Revenue Market Share by Region (2017-2022)
Figure 22. Global Drug-Eluting Stent Revenue Market Share by Region in 2021
Figure 23. U.S. Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Taiwan Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Philippines Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Vietnam Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Mexico Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Brazil Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Argentina Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Turkey Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Saudi Arabia Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. UAE Drug-Eluting Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Sales Market Share of Drug-Eluting Stent by Type (2017-2022)
Figure 48. Manufacturing Cost Structure of Drug-Eluting Stent
Figure 49. Manufacturing Process Analysis of Drug-Eluting Stent
Figure 50. Drug-Eluting Stent Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boston Scientific Medtronic Abbott Lepu Medical B. Braun Melsungen MicroPort Scientific Cook Medical Terumo Biosensors International Balton AlviMedica Medical Technologies Biotronik Shandong JW Medical Sino Medical Beijing AMSINO